Search Website
10th COGNO Annual Scientific Meeting
Tailoring Therapies for Brain Tumours: Challenges and Opportunities

Monday 23rd - Tuesday 24th October 2017
Rydges Melbourne Hotel, 186 Exhibition Street, Melbourne, VIC Australia


Professor Patrick Wen, MD

Professor of Neurology, Harvard Medical School
Editor-In-Chief, Neuro-Oncology
Director, Center for Neuro-Oncology
Dana-Farber Cancer Institute, USA

Dr Patrick Wen is Professor of Neurology at Harvard Medical School, Director of the Center For Neuro-Oncology at Dana-Farber Cancer Institute and Chief, Division of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital. He is also the Editor-in-Chief of Neuro-Oncology, Co-PI of the National Cancer Institute supported Adult Brain Tumor Consortium and a member of the Executive Committee of the Response Assessment in Neuro-Oncology Working Group. His work is focused on developing novel therapies for brain tumors, and improving response assessment and optimizing clinical trial design. For more information, please click here.

Professor Daniel Kelly, MD

Director, Pacific Brain Tumor Center & Pituitary Disorders Center 
Director, Pacific Neuroscience Institute
John Wayne Cancer Institute at Providence Saint John’s Health Center, USA
Photo and bio available shortly.
Professor Koichi Ichimura, MD PhD

Chief, Division of Brain Tumor Translational Research
National Cancer Center Research Institute, Japan
Photo and bio available shortly.
Dr Maciej Mrugala

Dr Maciej Mrugala received a medical degree in 1995 from the University of Warsaw Medical School in Poland, and a Ph.D. from the Copernicus University in Torun, Poland, in 2003. He completed neurology residency at the University of Massachusetts Medical School in 2003, where he was chief resident. He also completed fellowships in neuro-oncology at the Massachusetts General Hospital, and Dana-Farber Cancer Institute in Boston from 2003–2006, while concurrently earning a Master in Public Health at Harvard School of Public Health. In 2013, Dr Mrugala became Alexander M Spence Endowed Chair in Neuro-Oncology and the Chief of the Division of Neuro-Oncology at the University of Washington Medical School. In January 2017, Dr Mrugala joined the Mayo Clinic in Scottsdale/Phoenix, Arizona as a Senior Associate Consultant.

Dr Mrugala’s expertise is in primary glial brain tumors, primary central nervous system lymphoma and neurofibromatosis. He has participated as a principal investigator in multiple national and international clinical trials for gliomas. His research interests are in overcoming resistance of brain tumors to chemotherapy and in finding better ways to treat neurofibromatosis. He is also interested in neuro-oncology education and has been directing the education course in collaboration with Society for Neuro-Oncology and the American Academy of Neurology.

A/Prof Michael Back

A/Prof Michael Back is Director of Radiation Oncology for the Northern Sydney Cancer Centre at the Royal North Shore Hospital, Sydney and is also visiting consultant at the Central Coast Cancer Centre and Genesis Cancer Care NSW. His research interests include optimising radiation therapy target volume delineation and implementation of sophisticated techniques for patients with high grade glioma.  He is a member of the COGNO National Clinical Trial Committee for the EORTC CATNON Study, and is an active recruiter to international clinical trials through SNOG, COGNO and TROG.
Dr Bryan Day

Dr Bryan Day holds a PhD from the University of Queensland and is the Team Head of the Translational Brain Cancer Research Laboratory at the QIMR Berghofer Medical Research Institute. He and his team focus on the most common and aggressive form of brain cancer, Glioblastoma (GBM) in adults and the most common brain cancer in children, Medulloblastoma. He is a past Director for the Australian Society of Medical Research (ASMR) and is passionate about maintaining the ongoing success and sustainability of medical research in Australia. Among his achievements have been the development of a brain tumour bank at QIMR Berghofer and the characterisation of the receptor EphA3 as a therapeutic target in brain cancer. This research has led to clinical testing of a novel EphA3 therapeutic antibody for aggressive treatment refractory brain cancers. Dr Day’s main research focus is on understanding brain cancer cell biology and identifying novel therapeutic agents to treat these aggressive diseases.
A/Prof Frank Gaillard

A/Prof Frank Gaillard graduated from the University of Melbourne medical school in 1998. He trained as a radiologist at the Royal Melbourne Hospital, where he eventually returned as a consultant neuroradiologist after completing two years of neuroradiology fellowship training, and living and working in Canada.

He is the current Director of Research of the Radiology Department at Royal Melbourne Hospital and a Clinical Associate Professor in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. In addition to his work as a neuroradiologist, A/Prof Frank Gaillard has active research interests particularly in imaging of CNS tumours, neurodegenerative diseases, and computer aided MRI interpretation.

He is probably best known, however, as the Founder CEO of Radiopaedia.org, the largest collaborative online radiology resource, which forms one of the cornerstones of medical education throughout much of the world, particularly in developing countries.
A/Prof Mustafa Khasraw

A/Prof Khasraw is a clinical lead at the NHMRC Clinical Trials Centre of The University of Sydney and the Cooperative Trials Group for Neuro-Oncology (COGNO). In addition, he is a practising medical oncologist and neuro-oncologist at Royal North Shore Hospital and Northern Cancer Institute in Sydney. A/Prof Khasraw is leading several multi-centre clinical trials and research projects and serves on a number of research, advisory, policy and grant review panels.
Dr Zarnie Lwin

Dr Zarnie Lwin is a Senior Staff Specialist Medical Oncologist from the Royal Brisbane and Women’s Hospital, University of Queensland, Australia. 

She obtained her MBBS degree in Rangoon, Burma, then pursued physician training in Johannesburg, South Africa, medical oncology training in Australia, and undertook a Fellowship in Neurooncology and Health Services Research in Toronto, Canada.

Dr Lwin is Chair of COGNO Outreach including the COGNO Outreach Educational Preceptorship Program. She has convened several national Annual Scientific Meetings in Australia, and has been the Co-Convenor of the COGNO Ideas Generation Workshop for the past 4 years. 

She was the Scientific Program Co-Lead and Chair of the Social Committee for ASNO-COGNO 2016 in Australia which attracted delegates from 20 countries.
Dr Lwin is also the immediate ex Vice-Chair and Treasurer of the Medical Oncology Group of Australia (MOGA), and a current National Executive member.

Her main research interests include the interface where sociology meets oncology, and improving cancer outcomes for Culturally and Linguistically Diverse communities (CALD).
A/Prof Kerrie McDonald

A/Prof Kerrie McDonald is the Chair of the Cure Brain Cancer Neuro-oncology Group at the Lowy Cancer Research Centre, UNSW. She runs a team of 11 scientists and students working on personalised medicine where they are matching drugs to the patients’ tumour genome. The group specialise in biomarker development for use in pre-clinical and clinical trials.
Prof John Olver

Prof John Olver is a Consultant Physician in Rehabilitation Medicine, and a Professor in Rehabilitation Medicine in the Department of Medicine at Monash University. He is Medical Director of Rehabilitation at Epworth Healthcare, Melbourne, Australia, where he is also Coordinator of the Epworth Rehabilitation Acquired Brain Injury Programme. In 2008 he was appointed as Chairman of the Clinical Institute of Rehabilitation, Psychiatry and Pain Management at Epworth HealthCare and in 2009 was appointed to the Victor Smorgon Chair of Rehabilitation Medicine, Epworth HealthCare and Monash University. He is Director of the Epworth Monash Rehabilitation Medicine Research Unit (EMReM), the medical research arm of Epworth HealthCare Rehabilitation. He is Clinical Director of the Australasian Rehabilitation Outcomes Centre (AROC).

He is past-President of the Australasian Faculty of Rehabilitation Medicine (AFRM) and a past-President of the Asia-Oceanian Society of Physical and Rehabilitation Medicine (AOSPRM). He was a member of the President’s Cabinet of the International Society of Physical and Rehabilitation Medicine (ISPRM), as treasurer, for the last six years. Professor Olver was on the Council of the World Neurological Rehabilitation Federation (WFNR) as the Oceania Representative (2000-2016) and Convenor of the 2012 Melbourne WFNR Scientific Conference Committee. In 2014, he was a Recipient of a Member in the General Division of the Order of Australia (AM) “for significant service to medicine, particularly the treatment and rehabilitation of acquired brain injuries” and awarded the Centenary of Federation Medal for services to Road Safety in 2002.

Professor Olver's main research interests and a focus of publications concerns the outcomes following traumatic brain injury, management of spasticity and innovations in stroke rehabilitation. He has co-authored over 70 papers and 5 book chapters. In 2000, he completed a doctorate of medicine at The University of Melbourne, entitled “Videomotion Analysis of Gait and Sway Characteristics in Young Adults following Traumatic Brain Injury”.

Prof Stephen Rose

Prof Rose is the Director of CSIRO’s Probing Biosystems Future Science Platform and honorary Principal Research Fellow within the UQ Centre for Clinical Research, located at the Royal Brisbane and Women’s Hospital. His research interests include the development and application of novel medical imaging technology and clinical image informatics programs to improve the management and outcomes for patients with brain cancer.